Epstein-Barr virus loads in serum from patients with X-linked lymphoproliferative disease
| Case no. . | Clinical phenotype . | Time from disease onset . | Copy number of EBV (copies/mL of serum) . |
|---|---|---|---|
| Acute periods | |||
| 1 | Fulminant IM | 10 days | 5.3 × 106 |
| 2 | Fulminant IM | 18 days | 3.2 × 105 |
| 3 | Fulminant IM | 18 days | 1.3 × 105 |
| 5 | Fulminant IM | 34 days | 3.0 × 104 |
| Convalescence periods | |||
| 9 | Fulminant IM | 14 years | < 2.0 × 102 |
| 10 | EBV-associated Burkitt lymphoma (under chemotherapy) | 4 months | < 2.0 × 102 |
| 7 months | < 2.0 × 102 | ||
| Case no. . | Clinical phenotype . | Time from disease onset . | Copy number of EBV (copies/mL of serum) . |
|---|---|---|---|
| Acute periods | |||
| 1 | Fulminant IM | 10 days | 5.3 × 106 |
| 2 | Fulminant IM | 18 days | 3.2 × 105 |
| 3 | Fulminant IM | 18 days | 1.3 × 105 |
| 5 | Fulminant IM | 34 days | 3.0 × 104 |
| Convalescence periods | |||
| 9 | Fulminant IM | 14 years | < 2.0 × 102 |
| 10 | EBV-associated Burkitt lymphoma (under chemotherapy) | 4 months | < 2.0 × 102 |
| 7 months | < 2.0 × 102 | ||
IM indicates infectious mononucleosis. Other abbreviations are explained in Table 1.